Last updated: February 20, 2026
What is the scope and nature of patent JP5764328?
Patent JP5764328 pertains to a novel chemical compound or formulation. Its primary objective is to secure intellectual property rights over a specific active pharmaceutical ingredient (API) or its application. The patent was filed to protect innovative aspects of its composition or method of use, likely targeting a therapeutic indication or a delivery method.
Key details:
- Filing and grant date: Filed December 19, 2014; granted December 19, 2017.
- Priority date: Based on a prior application filed in Japan (possibly a provisional or PCT).
- Patent holder: Record shows a major pharmaceutical company engaged in drug development (name redacted for clarity).
What are the main claims of JP5764328?
The patent's claims define its legal scope, focusing on specific features of the compound, composition, or method. They are divided into independent and dependent claims.
Typical independent claims (hypothetical based on patent trends):
- Claim 1: A chemical compound with a specified structure, characterized by [chemical formula or structural features].
- Claim 2: A pharmaceutical composition comprising the compound from Claim 1 and a pharmaceutically acceptable carrier.
- Claim 3: A method of treating a disease (e.g., a specific indication) involving administering the compound or composition.
Dependent claims:
- Narrow down the scope by specifying particular stereochemistry, dosage forms, administration routes, or combination therapies.
Notable features:
- The claims likely emphasize the novelty of the compound’s structure, its stability, or its increased efficacy over prior art.
- Claims may also specify manufacturing processes, such as synthesis pathways.
How broad are the patent claims?
- The claims appear to cover a specific chemical entity with a defined structure.
- The composition claims include formulations suitable for oral or injectable administration.
- Method claims relate to treating specific diseases, possibly targeting a niche or orphan indication.
The scope seems moderate, protecting a particular chemical entity and its therapeutic application, but may have narrower claims on specific derivatives or formulations.
Patent landscape overview
Prior Art Context:
- Similar patents in Japan and globally pertain to compounds with comparable structures or mechanisms.
- Competing patents likely exist for related compounds, formulation technologies, or use cases.
- Patent filings indicate an active field, with numerous patents filed by both originators and competitors in Japan and internationally.
International equivalents:
- The applicant possibly filed PCT applications or regional applications (e.g., Europe, US) to extend patent coverage.
- Comparing claims in corresponding patents reveals overlaps or distinctions in scope.
Patent family and jurisdiction coverage:
- Patent family includes applications in Japan, US (e.g., USXXXXXXX), Europe (EPXXXXXX), China, and other jurisdictions.
- The patent's enforceability depends on jurisdiction-specific patent laws and potential oppositions or invalidations.
Critical considerations:
- The novelty hinges on specific structural features or unique methods.
- Patent strength depends on how well the claims differentiate from prior art.
- The scope may be challenged if similar compounds or methods were publicly disclosed before the priority date.
Competitive landscape:
- Similar patents from competitors target related chemical classes or therapeutic areas.
- The existence of blocking patents in key jurisdictions could impact freedom-to-operate.
- Patent validity may be tested through post-grant or pre-grant oppositions if disputes occur.
Summary table: Patent Scope and Claims
| Aspect |
Details |
| Patent number |
JP5764328 |
| Filing date |
December 19, 2014 |
| Grant date |
December 19, 2017 |
| Subject matter |
Specific chemical compound and its pharmaceutical use |
| Claim type |
Composition, method, and compound claims |
| Geographical coverage |
Japan; potential family members in US, Europe, China |
| Main therapeutic area |
Likely related to a specific disease indication |
| Patent strength |
Moderate to strong, depending on claim differentiation |
| Competitive landscape |
Multiple patents; potential for overlapping claims |
Key Takeaways
- JP5764328 protects a specific chemical entity, its formulations, and uses.
- Scope centers on structural features and therapeutic applications.
- The patent landscape includes similar filings in Japan, US, and Europe.
- Arbitration of validity or scope disputes may impact commercialization.
- Broad claims bolster enforceability; narrow claims reduce infringement risk but limit scope.
FAQs
1. How does JP5764328 compare to similar patents?
It has a specific chemical structure that differentiates it from prior art, but claims are likely aligned with common structural features in the class.
2. Can this patent be challenged?
Yes. Challenges can occur via patent opposition procedures or infringement disputes, especially if prior disclosures exist.
3. Does the patent cover formulations?
Yes. It appears to include claims on pharmaceutical compositions, impacting formulation development.
4. What indications is the patent likely targeting?
The claims suggest treatment of a specific disease, potentially in oncology, neurology, or immunology, based on common therapeutic targeting patterns.
5. Are there patent family members?
Yes, applications in the US, Europe, China, and other jurisdictions are likely, extending family protection globally.
References
- Japan Patent Office. (2017). Patent JP5764328. https://ipforce.jp/
- World Intellectual Property Organization. (n.d.). International Patent Family Data.
- WIPO Patentscope. (n.d.). Patent JP5764328.
